Viva Biotech Holdings (HK:1873) has released an update.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Viva Biotech Holdings has announced that all proposed resolutions at its Annual General Meeting on June 26, 2024, were passed by shareholder votes, including the re-election of directors, approval of auditor remuneration, and amendments to the company’s share capital structure. The AGM saw the adoption of audited financial statements and reports, the re-appointment of Ernst & Young as the company’s auditor, and the granting of mandates to allot and repurchase company shares. With a strong shareholder backing of over 50% for ordinary resolutions and over 75% for the special resolution, the company’s directive for the coming year has been solidly affirmed.
For further insights into HK:1873 stock, check out TipRanks’ Stock Analysis page.